Medicxi

News, insights, analysis and data

Medicxi overview

Stories about Medicxi

Picture of the Company

Medicxi raises $449.17m

The London-based investment firm held a final close of its venture capital healthcare fund.

Picture of the Company

Medicxi Ventures raises €300m

View the latest capital raises

Medicxi contact information

Offices

marker icon25 Great Pulteney Street, London, W1F 9LT, United Kingdom
Showing 1 of 3 Medicxi offices

Contacts

NameJob titleLocationEmail
user imageMr. Francesco De Rubertis
Job titleCo-Founder and Partner
LocationGeneva, Switzerland
Emaillock image-----------
user imageMr. David Grainger
Job titleCo-Founder and Venture Partner
LocationLondon, United Kingdom
Emaillock image------
user imageMr. Kevin Johnson
Job titleCo-Founder and Venture Partner
LocationLondon, United Kingdom
Emaillock image----------
user imageMr. Richard Lee
Job titleCo-Founder and Operating Partner
LocationLondon, United Kingdom
Emaillock image-------

Medicxi funds managed

Closed funds: 9

FundFund sizeClose dateStrategy
Fund sizelock image-----
Close dateNov 2025
Strategylock image-----
Fund sizelock image-------
Close dateJul 2023
Strategylock image-----------
Fund sizelock image-------
Close dateJul 2019
Strategylock image-----------

Stories that mention Medicxi

Mass PRIM allocates $460m to private equity funds

The US-based public pension has backed eight private equity funds.

CHART: The biggest dedicated life sciences capital raisers

Dedicated life sciences firms with strong AUM growth have been prime targets for larger GPs recently – here's a list of firms ranked by capital raised.

PEI Awards 2020: Secondaries winners

Awards for the strategy in 12 categories, including Firm, Deal, Law Firm and Advisor across EMEA, the Americas and Asia-Pacific.

GHO Capital's biggest European healthcare fund in context

Specialist healthcare manager GHO has raised €975m for its second vehicle, the largest-ever European fund dedicated to healthcare and life sciences.

Massachusetts PRIM releases 5-year carry data

PRIM, which has been building on its co-investment programme to cut fees and carry, has steadily reduced carried interest expenses in the past few years.